| abstract |
The present invention relates to at least one PI3K inhibitor of formula I or a pharmaceutically acceptable salt thereof, and at least one HDAC inhibitor, such as a compound of formula II or a pharmaceutically acceptable salt thereof; or at least 1 Relates to a pharmaceutical composition comprising two PI3K inhibitors, for example a compound of formula I or a pharmaceutically acceptable salt thereof, and at least one HDAC inhibitor of formula II or a pharmaceutically acceptable salt thereof. Kits and methods comprising the above compositions are also provided. |